Indan pharma stocks declined after US President Donald Trump hiked tariffs to 100%. (Photo: Sun Pharmaceutical Industries/Facebook)

Show Quick Read Summary is AI Generated. Newsroom Reviewed

Sun Pharmaceutical Industries Ltd. declined nearly 5% on Friday as Trump announced 100% tariff on the Pharmaceutical sector unless the company has manufacturing capacity in the United States.

Other Pharmaceutical stocks seeing decline are Cipla Ltd., Dr Reddys Laboratories Ltd., Lupin Ltd. and Biocon Ltd., however the impact on these companies is largely contained since the US tariffs mainly target branded and patented drugs, where multinational companies like Pfizer Inc. and Novo Nordisk Inc. dominate.

It is yet unclear whether complex generics and specialty drugs from India could also face scr

See Full Page